Context: Stress fractures are repetitive use injuries in which recurrent strains lead to material fatigue and microarchitectural discontinuities. They account for up to 20% of athletic injuries, more often in women and in the setting of track-and-field events. In women, menstrual disturbances, low body mass index, low energy intake, and sometimes low bone mass, may be contributing factors. There are no standard protocols for evaluation or management of stress fractures.
There are other types of stress fractures that need to be differentiated from the fractures of the athlete, such as insufficiency or pathological fractures (7) . Insufficiency fractures can be seen in conditions of vitamin D deficiency or resistance. Looser lines are characteristic of these kinds of osteomalacic fractures (8) . Other conditions, such as osteomyelitis and hypophosphatasia, can present as insufficiency fractures (9) . More recently, the fractures associated with long-term bisphosphonate use are being considered to be a variant of the insufficiency fracture (10) . A pathological fracture, which can sometimes masquerade as an insufficiency fracture, is reserved for primary and metastatic tumors of bone (11) . Stress fractures account for up to 20% of athletic injuries. In addition to professional athletes, runners who average more than 25 miles per week constitute a group at increased risk for stress fractures (12) . Stress fractures are said to occur more commonly in women and in those who engage in track-and-field events. Anatomically, the tibia, fibula, and metatarsal bones are the most frequently affected sites (13, 14) . However, other less common sites such as the distal femur, femur neck, medial malleolus, distal radius, and olecranon have been described (15) . In some cases, fractures to these other sites are seen more commonly in certain sports, such as first rib fracture in swimmers and baseball players and humeral fractures in tennis players (16, 17) .
Although the pathogenesis of stress fractures is not completely understood, it is clearly multifactorial (18) . Biomechanical factors play a key role, but numerous other extrinsic as well as intrinsic factors contribute (5, 19) . The complex pathogenesis may help to explain why some individuals develop stress fractures and others, under similar circumstances, do not. In this review, we summarize our current understanding of the pathophysiology, clinical risk factors, and management of stress fractures.
Physiology and Pathophysiology
The osteocyte is the most abundant bone cell (20) . It is now known that the osteocyte is a master orchestrator of osteoblast and osteoclast function. The complex dendritic network of osteocytes senses biomechanical stress and transmits associated signals to the osteocyte cell body, which in turn responds by secreting signaling molecules such as sclerostin and fibroblast growth factor 23 (21) . This signaling function, in particular, may have some role in the pathogenesis of stress fractures, given that the osteocyte is the first to detect microdamage at the cortical surface of bone tissue (22) . Dooley et al. (23) demonstrated that cyclic loading itself may cause fatigue failure in the dendritic processes of osteocytes, compromising these signaling mechanisms and thus impeding the physiological mechanisms of repair (23) .
Furthermore, it was demonstrated that repetitive strains lead to such impairment of signaling that under these conditions, as little as one-tenth of usual strain levels can lead to spontaneous microarchitectural breaks (2) . In more quantitative terms, the number of cycles to failure was inversely correlated with the determinant or threshold strain level.
In animal models of stress fracture, more numerous apoptotic osteocytes are seen contiguous to the fracture line along with a specific reduction in the expression of sclerostin, a key regulator of the osteoanabolic Wnt signaling pathway. Teleologically, by expressing less sclerostin, the dying osteocyte is signaling for more bone formation.
Following the stress fracture, it is hypothesized that osteocyte apoptosis and subsequent expression of cytokines, such as vascular endothelial growth factor, transforming growth factor-b, cyclooxygenase-2, and interleukin 6, are early signaling events that lead to recruitment of osteoclast precursors to the site of remodeling and for new bone formation to occur. Wu et al. (24) observed increased expression of interleukin 6 and cyclooxygenase-2 in osteocytes adjacent to the damaged area in the ulna of mature female Wistar rats when they were repetitively loaded. Control, unloaded animals did not demonstrate these effects. Furthermore, the expression of sclerostin protein was significantly reduced in osteocytes adjacent to the stress fracture region when compared with controls. These data reinforce the role of osteocyte apoptosis as fundamental to repair mechanisms that are related to fatigue-related bone damage.
The time course of the clinical expression of a stress fracture is generally 2 months after the individual has substantially and rather abruptly increased the level of exercise (25) . This repetitive overloading, for which the skeleton is not "prepared," leads to greater elastic deformation followed by even greater plastic deformity (26) . The ultimate results are microcracks. Microdamage is repaired by a process that includes new bone formation, as mentioned previously. However, if the repetitive nature of the process is sufficiently great, microdamaged elements accrue at a faster rate than the repair process can accommodate (27) . At some point, the accumulation of microdamage is translated into a clinical event, the stress fracture. In summary, a stress fracture is, in its classical form, the clinical output of a culmination of repetitive mechanical forces that exceed intrinsic repair mechanisms. It is not necessarily due to diminished skeletal strength, although this could play a role (see Intrinsic Risk Factors).
Extrinsic and Intrinsic Risk Factors
There are many extrinsic and intrinsic factors that can place a given individual at risk for a stress fracture (2, 5) . Several of these factors are difficult to analyze independently and are not even clearly etiologic. In addition, individual susceptibility to the development of stress fractures seems to exist among those who exercise, such that under the same conditions of exercise or excessive exercise, a given individual may or may not be at the same risk.
The extrinsic factors relate to the type of the sport, quality of footwear and equipment, and environmental factors, such as the running surface itself (28, 29) . An insufficient fitness level or an abrupt increase in the intensity of training regimens can also contribute to the development of stress fractures (30) . However, high training volume is a virtual prerequisite for stress fractures. Studies clearly have demonstrated that high training mileage, for instance, more than 40 miles (about 67 km) per week (e.g., in runners), and long exercise periods, such as more than 5 hours of daily training (e.g., in dancers), increase the risk for stress fracture (6, 31) .
Numerous intrinsic factors have been reported to be associated with an increased risk of stress fracture (30) . Women have a higher incidence of stress fractures than men (32) . Small tibial width was shown to be a risk factor, which helps to explain, at least in part, this sex difference (3). Furthermore, hormonal and nutritional factors such as hypoestrogenism and low energy intake substantially increase the risk of stress fractures (33) . An example of an extreme situation is the "female athlete triad" that was first described in 1992 by the presence of oligomenorrhea or amenorrhea, low bone mass, and an energy deficit (34) . In 2007, its definition was modified to include a spectrum of dysfunction related to irregular menstrual function, reduced bone mineral density (BMD), and low energy availability (35, 36) . The revised definition does not require all 3 components of this triad. Athletes who experience only 1 or 2 features of the triad are now included. A meta-analysis showed an increase in prevalence of the "triad" with the new definition (35) .Two elements of the triad had a prevalence of 2.7% to 27%, whereas any 1 element of the triad had a prevalence of 16% to 60%. It is important to point out that the prevalence of the triad in those activities that emphasize weight control, such as ballet, gymnastics, or endurance running, is much higher than in other activities in which weight is not such a major element to the sport or exercise (37) . Energy restriction in female athletes is very common, ranging from failure to increase caloric consumption to match physical activity, to frank reduction in energy intake, to pathologic eating disorders. This is very important because energy repletion remains the cornerstone of treatment of women who are so afflicted (35) .
Menstrual dysfunction in active females occurs with a frequency of 12% to 79%. It is more prevalent in ballet dancers (38) . In runners, training duration correlates positively with menstrual dysfunction. Amenorrhea is present in up to 60% of females when training mileage is more than 70 miles per week (;115 km) (36) . Furthermore, energy restriction influences the hypothalamicpituitary axis, leading to a reduction in gonadotropin secretion. Athletic amenorrhea is strongly related to caloric restriction. In addition, body mass index and lean tissue mass are directly related to low BMD (39) . Return of menstrual cycles depends on improvement in nutrition and weight gain (40) . Similarly, a positive effect on bone mass is clearly related to improved energy balance and weight gain (41) .
The use of oral contraceptive pills (OCPs) is an important issue among athletes (42) . The benefits of their use go beyond contraception per se. OCPs reduce the risk of anemia by reducing menstrual blood loss. The convenience factor is also noteworthy: without cycles, travel, training, and competitions are not encumbered by menstruation. Furthermore, without menstrual periods, premenstrual symptoms are reduced, which could in turn have a positive effect on performance (42) . However, besides these advantages of OCPs for athletes, adherence to them is classically uncertain, and women who stopped taking OCPs had significantly lower percentages of body fat, fewer menstrual periods per year, and more disordered eating than women who adhered to OCPs. A relationship between use of OCPs and bone density is controversial (43) (44) (45) . Some studies have shown greater bone mass in current or past users of OCPs than in nonusers, whereas other studies have not documented a positive effect of OCPs on bone mass in either normally active women or athletes (46) . Regarding the association between OCPs and fractures, the studies are not consistent. The relationship between OCP use and subsequent occurrence of fracture later in life was evaluated in a cohort of 46,000 women. The risk of subsequent fractures among women who had used OCPs for any time period was significantly greater than for women who had never used them (47) . In contrast, more recently, a systematic review of 14 observational studies did not confirm an overall association between OCPs and fracture risk (48) .
With specific regard to stress fractures, some studies have observed that the use of OCPs presents a protective effect in female runners (33, 42, 49) . One hundred fifty competitive female runners, 18 to 26 years old, were randomly assigned to OCP (30 mg of ethinyl estradiol and 0.3 mg of norgestrel) or control (no intervention) for 2 years. The authors concluded that OCPs may reduce the risk of stress fractures (46) .
A clear negative impact of medroxyprogesterone acetate (DMPA) on bone health has been shown. DMPA use within the last 2 years was more likely to be associated with a stress fracture in comparison with use of oral contraception or no hormonal contraception. The risk associated with DMPA could relate to the fact that users become estrogen deficient when they are receiving the progestational agent. Bone density also decreases in this setting (50, 51) .
In athletes, there are only a few studies on the role of nutrients and dietary patterns in relation to the risk of stress fractures. Nieves et al. (19) evaluated dietary variables in 125 female competitive distance runners (age 10 to 26 years old), of whom 17 experienced at least 1 stress fracture during follow-up. The results of this prospective study indicated that intake of low-fat dairy products and their major components (calcium, vitamin D, and protein) was related to higher incremental BMD and lower stress fracture risk. Interestingly, the protection afforded by these dietary components was independent of BMD. Another study evaluated female navy recruits for 8 weeks of basic training and observed that those who were randomly assigned to receive 2000 mg of calcium plus 800 IU of vitamin D had a 20% lower incidence of stress fracture than the control group (52) . The authors pointed out that there is strong rationale for calcium supplementation in this population, arguing that positive calcium balance is essential for bone mineralization and necessary for maximal bone adaptation to mechanical loading. In addition, intense physical activity stimulates bone formation which may, in turn, increase calcium demand. Furthermore, potassium intake from the consumption of fruits and vegetables has been implicated as having a salutary effect on BMD, independent of calcium (53, 54) .
Diagnosis and Evaluation of Stress Fractures

Imaging
Stress fractures can be challenging to diagnose. Suspicion is raised when the athlete complains of increased focal sensitivity and tenderness, particularly at the onset and at the end of a training period (55) . The physical examination typically finds tenderness over the involved bony area with or without localized swelling (56) . The diagnosis is confirmed by imaging, but routine x-rays give a high false-negative rate, particularly at the onset of the stress fracture (57) . Currently, MRI is the most sensitive and specific diagnostic tool. It is the gold standard, regardless of the location of the stress fracture. MRI has the ability to evaluate both soft tissue and bone edema ( Figs. 1 and 2 ). This is an important point, namely, that the early sign of stress fracture is edema of both bone tissue and adjacent soft tissue areas. These early signs are identified by MRI as early as 1 or 2 days after the onset of symptoms (58) ( Table 1) .
Ultrasonography was demonstrated to be a sensitive and specific technique in early diagnosis of metatarsal bone stress fractures in a series of cases (59) . In addition, bone scintigraphy (technetium-99m) is sensitive to states of increased bone remodeling and can show signs of fracture as early as 3 to 5 days after the onset of symptoms. Computed tomography (CT) is used when MRI is contraindicated. CT is also useful diagnostically when stress fractures have become chronic and are associated with low bone turnover (60) . Other techniques, such as positron emission tomography/CT, have been used to detect insufficiency fractures, and single photon emission CT has been used for investigating stress fractures involving the dorsal spine (61) .
An interesting point regarding the detection of edema in the early onset of stress fractures relates to the condition called transient osteoporosis of the hip. This diagnosis was thought to be a result of acute and rapid bone loss in 1 region of the skeleton, usually the hip. Edema of the femoral head or neck is a common feature. However, with higher imaging modalities, it seems more likely that there is cortical discontinuity; thus, this diagnosis may actually be masquerading as another variant of the stress fracture (62) .
BMD
Features common to many who sustain a stress fracture (e.g., low BMD, reduced energy intake along with reduced intake of calcium and vitamin D) raise the conundrum of whether stress fractures reflect an intrinsic abnormality in skeletal mass or quality among those who appear to be predisposed. However, studies attempting to address this possibility have reported differing results. Myburgh et al. (49) found that BMD of the spine and hip was significantly lower in athletes with stress fractures than in controls. In contrast, Giladi et al. (63) and Frusztajer et al. (64) found no difference in BMD of dancers and male Israeli military recruits with stress fractures and matched controls. Lauder et al. (65) were the first to examine the role of BMD among 185 activeduty female army soldiers, 27 of whom experienced a stress fracture. After controlling for confounding variables known to be associated with both stress fractures and BMD, a strong negative relationship between the probability of stress fractures and BMD of the femoral neck was observed. Conversely, BMD of the lumbar spine was not a statistically significant predictor of stress fractures. This might be expected, given that the hip region contains more cortical bone than the lumbar spine and that stress fractures typically affect cortical bone. But not all studies are consistent with this premise, either. Recently, for example, 1 study evaluated BMD and structural differences among marine recruits who suffered a stress fracture during 32 weeks of training and uninjured control recruits, matched for age, body weight, height, and aerobic fitness. BMD at the lumbar spine, femoral neck, and whole body was consistently lower in the stress fracture group than in the control group. In addition, a negative correlation between bone cross-sectional area and BMD at the 38% tibial slice was found. Structural bone parameters of the tibia, measured by peripheral quantitative CT, showed evidence of fundamental differences in bone structure in all slices of the tibia in healthy military members with stress fractures compared with those without fractures (66) . These findings suggest that bone quality may be compromised in individuals who develop stress fractures. There is no systematic bone biopsy study with histomorphometry on individuals who have experienced a stress fracture.
Laboratory evaluation
A small number of studies have reported laboratory evaluation in individuals with stress fractures. Vitamin D has been of interest. One study measured the serum concentrations of 25-hydroxyvitamin D [25(OH)D] in 53 patients with confirmed stress fractures, within 3 months of diagnosis (67) . An association was found in patients with a stress fracture and a 25(OH)D level ,40 ng/mL (100 nmol/L). Furthermore, in a prospective study evaluating a large number of recruits, a serum 25(OH)D concentration ,20 ng/mL (50 nmol/L) was associated with a higher incidence of stress fracture than levels .20 ng/mL (68) . In contrast, Wentz et al. (69) showed that the majority of American distance runners residing at 30.4°north maintained sufficient vitamin D status. In a prospective study in male military recruits, 25(OH)D levels did not differentiate fracture cases from others. However, there was a significant association of stress fractures with higher parathyroid hormone (PTH) levels. In fact, their findings show that serum levels of PTH were 60% higher in those with fractures (70) . Whether higher PTH levels might relate to subclinical vitamin D deficiency or to resistance, or whether other causes of secondary hyperparathyroidism are at play, is not known.
A few studies have evaluated the relationship between biochemical markers of bone turnover and stress fractures. press.endocrine.org/journal/jcem
Valimaki et al. (70) found that bone turnover marker levels were similar in men with and without stress fractures. Similarly, Strohbach et al. (71) showed no difference in serum cross-linked collagen telopeptide concentration between female recruits with stress fractures and matched controls at any stage of training. Interestingly, it was also observed that bioavailable serum insulin-like growth factor 1 (IGF-1) levels decreased during basic training among women with stress fractures, whereas women without fractures had increased bioavailable IGF-1. These findings suggest that IGF-1 concentrations per se and/or their response to physical training may help to account for stress fracture susceptibility.
Treatment
The treatment of stress fractures must focus not just on the recovery of the injury but also on the prevention of new events. Furthermore, for competitive athletes, treatment ideally would speed recovery so that the athlete could more quickly return to training or competition. Activity modification should be considered as the first therapeutic step (15) . For a period of time, activity modification may consist of a temporary curtailment of the activity that was associated with the stress fracture. Adequate recovery time is important to ensure proper healing (72) . This point recognizes, however, that individuals who have suffered a stress fracture are among those least likely to tolerate an enforced regimen of inactivity. Thus, implementing this reasonable directive could be challenging. Furthermore, targeted actions with respect to several extrinsic factors, such as footwear and training surfaces, might be helpful. In general, return to sports should start gradually after the patient is free from pain for a 10-to 14-day period. Formation of bone callus as well as obliteration of the fracture line seen on radiographs, MRI scans, or CT scans may help to establish recovery (55).
Nutritional and medical therapy
Part of the therapeutic regimen should include sufficient calcium, as documented by the study by Lappe et al. (52) , on the basis of which it would seem reasonable to ensure a total daily intake of 2 g of calcium. If the patient's calcium intake is inadequate to amount to this level, supplementation would be necessary. This amount of calcium intake is within the safety guidelines of the Institute of Medicine (73, 74) . Also important is ensuring sufficient vitamin D intake which, according to Lappe et al. (52) , would be 800 IU per day.
Medicinals include analgesics for pain relief. Bisphosphonates have been used in a few studies for the prevention and treatment of stress fractures. In 5 cases, intravenous pamidronate was reported to be effective in reducing the time needed before returning to training after the stress fracture (75) . In a retrospective study, the safety and efficacy of intravenous ibandronate and highdose vitamin D were evaluated for bone marrow edema syndrome (a condition that is not necessarily a forerunner of the stress fracture) and stress fracture in 25 highperformance athletes. Bone marrow edema is a reversible but painful increase in interstitial fluid within the bone marrow. The exact pathogenetic processes are unknown. After ibandronate administration, reduction of pain at rest and under strain along with improved mobility were reported in 64% of subjects within 2 weeks. For those who had an early diagnosis and rapid Bone marrow edema in T2 weighted Grade 3 Bone marrow edema in T1 and T2 weighted Grade 4a
Intracortical signal abnormality Grade 4b
Fracture line present onset of treatment, the time needed before returning to activities was shortened (76) . Conversely, a study of military recruits showed that risedronate for 12 weeks was not effective in reducing stress fracture incidence, delaying time to onset, or decreasing the severity of fractures (77) . Bisphosphonates are not approved for this indication by the US Food and Drug Administration. The potential therapeutic use of teriparatide, an osteoanabolic agent approved for the treatment of osteoporosis, calls attention to the complex pathophysiology of fracture healing. Clearly, active bone remodeling is important for fracture healing. Therefore, therapies that increase bone remodeling activity with a focus on bone formation would be attractive options. However, the few clinical trials that have been designed with this end point in mind have not yet established that teriparatide accelerates fracture healing in osteoporosis (78) . In animal models, teriparatide has been shown to improve callus volume, bone mineral content, and rate of successful union at fracture sites. Fewer studies have evaluated this potential effect of teriparatide on healing fracture in human subjects. Aspenberg et al. (79) examined the effect of placebo compared with teriparatide administered in doses of 20-and 40-mg/d to 102 female patients with distal radius fractures. These patients were all between 45 and 85 years of age and their fractures were being treated conservatively. They found that the median time to first radiographic evidence of healing was 9.1 weeks in the placebo group compared with 7.4 and 8.8 weeks in the groups treated with 20 mg and 40 mg of teriparatide, respectively. Post hoc analysis demonstrated a significant difference between the placebo group and those patients treated with 20 mg daily. The primary end point, namely, effect on fracture healing at the 40-mg dose, was not significantly different from the control group. Subsequently, these authors studied the qualitative appearance of the callus 5 weeks after fracture and observed that teriparatide appeared to improve early callus formation in distal radial fractures (80) . One study of women with vertebral fracture demonstrated that short-term teriparatide treatment reduced the progression of vertebral body collapse (81 (83) . Recently, a panel of experts published a consensus statement on fracture healing and considered the use of teriparatide for fracture healing as efficacy level of grade 7 on a scale of 1 to 9 (84). This minimal consensus agreement is undoubtedly due to the paucity of clinical trials and the need for more evidence.
The use of teriparatide to accelerate fracture healing has been extended to athletes who sustain major traumatic fractures. The evidence that teriparatide is beneficial in this regard is still anecdotal at this point. Clinical case reports of patients with impaired healing of metatarsal fractures show successful bony union of the fracture after the use of teriparatide (85) . In the initial stages of fracture healing, during which an increase in bone formation is required, teriparatide increases bone formation through stimulation of osteoblasts and consequently optimizes the natural healing process of fractures. No study has been conducted evaluating the effect of teriparatide on stress fractures. Alternatives to promote bone repair have been described. Because of bonding properties, methyl methacrylate has been used to promote bone healing after cranioplasty and for treatment of tooth root fractures (86) . Low-intensity pulsatile ultrasound has been shown to accelerate fracture healing in both animal models and clinical trials (87) .
Protocols for management of stress fracture, including investigation, preventive strategies, and treatment, are lacking in the literature. On the basis of this review, we suggest an approach as described in Table 2 . Prevention and management strategies could be developed on the basis of this article. With regard to evaluation, an uncomplicated evaluation would include a routine chemistry panel and 25(OH)D levels. Thyroid function tests, again, are straightforward and could have bearing on skeletal health in the context of hyperfunction. Urinary calcium excretion could be a useful clue to the adequacy of dietary calcium. If low, one would ask more questions about dietary calcium. If high, concerns about a calciumlosing state would be raised. Finally, BMD assessment would seem reasonable in subjects who sustain recurrent stress fractures. BMD assessment is safe and, like evaluation of urinary calcium excretion, could unmask an underlying metabolic bone disease. BMD assessment can also be justified, given that it is an inexpensive test in many countries at this point.
Summary and Future Directions
Stress fractures are common among athletes and military recruits. A protocol for investigation and follow-up is lacking. Treatment regimens are not well established. Furthermore, with advances in our understanding of bone physiology and bone cell biology, new factors that have not yet been studied in stress fractures may ultimately be shown to play a role in their pathophysiology. For example, sclerostin, a key skeletal regulator of bone remodeling, might play an important part. An increase in sclerostin levels may impair bone repair and consequently lead to stress fractures or impair stress fracture healing. However, if sclerostin levels were to be lowered with the use, for example, of an antisclerostin agent, fracture healing could be accelerated. Analogs of parathyroid hormone, such as teriparatide, might be relevant to the hypothesis that fracture healing is accelerated when bone remodeling is enhanced (89) . Furthermore, new drugs used in the treatment of postmenopausal osteoporosis may show promise. The RANKL inhibitor denosumab is a noteworthy candidate by virtue of its positive effect on cortical bone (90) . In addition, newer osteoanabolic drugs under investigation, such as abaloparatide, an analog of parathyroid hormone-related protein, and romosozumab, an antibody against sclerostin, may show promise. Greater understanding of the pathophysiology of stress fractures and more attention to the potential utility of current and future bone-active therapeutics may well yield approaches that will more effectively deal with the problem of stress fractures.
